The NYT had an interesting piece this morning on how insurers are trying to reduce the cost of treating cancer. While the piece notes that much of the cost is related to the high price of new cancer drugs it would have been worth mentioning that this is the result of government granted patent monopolies. If the government used a different mechanism for financing drug development and allowed drugs to be sold at the free market price, all of these treatments would be relatively low cost. The doctors would be able to choose the one that they viewed as best for their patient without worrying about the cost.
Please login to comment
  • No comments found

Site Maintenance

"The CEPR website currently takes longer to load than usual. We hope to have this and other issues addressed shortly. While this much needed site maintenance is taking place, our content is still available so please continue to slooowwwly surf the pages of our site. Thank you for your patience."